The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of NY-ESO-1 vaccine + ipilimumab (IPI) in patients with unresectable or metastatic melanoma.
 
Craig L. Slingluff
Consulting or Advisory Role - Immatics (Inst); Polynoma (Inst)
Research Funding - 3M (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme (Inst); Theraclion (Inst)
Patents, Royalties, Other Intellectual Property - Licensing and Ventures Group of the University of Virginia
 
Hassane M. Zarour
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Tesaro (Inst)
 
Michael A. Postow
Honoraria - Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Incyte; Merck; Newlink Genetics; Novartis
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Infinity Pharmaceuticals (Inst); Novartis (Inst); Rgenix; Rgenix
 
Philip Adam Friedlander
Stock and Other Ownership Interests - allergan; Avalanche Biotechnologies; Bristol-Myers Squibb; Clovis Oncology; Incyte; Merrimack
Consulting or Advisory Role - Array BioPharma; Castle Biosciences; Genentech; Seagen
Travel, Accommodations, Expenses - Array BioPharma; Castle Biosciences; Seagen
 
Craig E. Devoe
No Relationships to Disclose
 
Kelly Smith
No Relationships to Disclose
 
Donna Deacon
No Relationships to Disclose
 
Mary J. Macri
Stock and Other Ownership Interests - Pfizer
 
Aileen Ryan
Stock and Other Ownership Interests - Amgen; Immunogen; Teva
 
Ralph Rudolph Venhaus
Stock and Other Ownership Interests - Soligenix
 
Jedd D. Wolchok
Stock and Other Ownership Interests - Adaptive Biotechnologies; Imvaq Therapeutics; Potenza Therapeutics; Serametrix; Tizona Therapeutics, Inc.; Trieza Therapeutics
Honoraria - Regeneron
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Ascentage Pharma; Beigene; Bristol-Myers Squibb; Chugai Pharma; FSC Pediatrics; Genentech; Lilly; MedImmune; Merck; Ono Pharmaceutical; Polaris; Polynoma; Potenza Therapeutics; Sellas Life Sciences; Tizona Therapeutics, Inc.
Research Funding - Bristol-Myers Squibb (Inst); F-Star Therapeutics; Genentech/Roche (Inst); Incyte (Inst); Leap Therapeutics (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst)
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent for use of oncolytic Newcastle Disease virus.; I am a co-inventor on an issued patent for DNA vaccines for treatment of cancer in companion animals.
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Bristol-Myers Squibb; Chugai Pharma; Janssen; Ono Pharmaceutical; Roche